10-Nov-2020 - Study of neuron-astrocyte interaction using multi-modal integrated bioinformatics workflow identifies a new potential therapeutic target for ALS

Death receptor-6 (DR6) on motor neuron was identified as possible disease modifier of Amyotrophic Lateral Sclerosis by the researchers of the Centro Dino Ferrari, University […]

17-Sep-2020 - New therapies and systemic impact of Spinal Muscular Atrophy

Our team from the Dino Ferrari Center of the University of Milan discusses the advancements and challenges of new therapies for patients with Spinal Muscular […]

19-May-2020 - Amyotrophic Lateral Sclerosis: the role of a miRNA identified as a possible therapeutic target

A recent study published on the international journal Progress in neurobiology and carried out by the research group (Dr. Monica Nizzardo and Dr. Mafalda Rizzuti) […]

17-Mar-2020 - SMARD1 Natural History Study at Centro Dino Ferrari Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico

Spinal muscular atrophy with respiratory distress type 1 (SMARD 1)is a rare, autosomal recessive neuromuscular disease characterized by degeneration of the motor neuron that manifests […]

25-Feb-2020 - A recent study investigated potential treatment biomarkers of spinal muscular atrophy (SMA) type 3

A recent study published on the Journal of Cellular and Clinical Medicine and conducted by the researchers of the Centro Dino Ferrari, University of Milan, […]

18-Feb-2020 - ALS and SMA: study of molecular mechanisms in resistant neurons identifies a new potential therapeutic target

SYT13 is an oculomotor restricted gene, identified as possible disease modifier of Amyotrophic Lateral Sclerosis and Spinal Muscular Atrophy (SMA), by the researchers of the […]

Archive

Scientific Meetings

Press Review